au.\*:("NICOLAU, D. P")
Results 1 to 25 of 51
Selection :
The integration of pharmacokinetics and pathogen susceptibility data in the design of rational dosing regimensMAGLIO, D; NICOLAU, D. P.Methods and findings in experimental and clinical pharmacology. 2004, Vol 26, Num 10, pp 781-788, issn 0379-0355, 8 p.Article
A Pharmacodynamic Simulation to Assess Tigecycline Efficacy for Hospital-Acquired Pneumonia Compared with Other Common Intravenous AntibioticsKUTI, J. L; DOWZICKY, M; NICOLAU, D. P et al.Journal of chemotherapy. 2008, Vol 20, Num 1, pp 69-76, issn 1120-009X, 8 p.Article
Pharmacodynamic rationale for short-duration antibacterial therapyNICOLAU, D. P.The Journal of infection. 2002, Vol 44, pp 17-23, issn 0163-4453, SUPAConference Paper
Prophylaxis of acute osteomyelitis with absorbable ofloxacin-impregnated beadsNICOLAU, D. P; LIN NIE; TESSIER, P. R et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 4, pp 840-842, issn 0066-4804Article
Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumoniasBELLIVEAU, P. P; FREEMAN, C. D; NICOLAU, D. P et al.American journal of health-system pharmacy. 1996, Vol 53, Num 9, pp 1024-1027, issn 1079-2082Article
Serum bactericidal activity of ceftazidine : Continuous infusion versus intermittent injectionsNICOLAU, D. P; NIGHTINGALE, C. H; BANEVICIUS, M. A et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 1, pp 61-64, issn 0066-4804Article
Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulareONYEJI, C. O; NIGHTINGALE, C. H; TESSIER, P. R et al.The Journal of infectious diseases. 1995, Vol 172, Num 3, pp 810-816, issn 0022-1899Article
Bioavailability of fluconazole administered via a feeding tube in intensive care unit patientsNICOLAU, D. P; CROWE, H; NIGHTINGALE, C. H et al.Journal of antimicrobial chemotherapy (Print). 1995, Vol 36, Num 2, pp 395-401, issn 0305-7453Article
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosaKLEPSER, M. E; PATEL, K. B; NICOLAU, D. P et al.Antimicrobial agents and chemotherapy. 1995, Vol 39, Num 11, pp 2503-2510, issn 0066-4804Article
Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophagesONYEJI, C. O; NIGHTINGALE, C. H; NICOLAU, D. P et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 3, pp 523-527, issn 0066-4804Article
Performance of the PIRO score for predicting mortality in patients with ventilator-associated pneumoniaFURTADO, G. H; WISKIRCHEN, D. E; KUTI, J. L et al.Anaesthesia and intensive care. 2012, Vol 40, Num 2, pp 285-291, issn 0310-057X, 7 p.Article
Intrapulmonary concentrations of telithromycin : Clinical implications for respiratory tract infections due to Streptococcus pneumoniaeONG, C. T; DANDEKAR, P. K; SUTHERLAND, C et al.Chemotherapy (Basel). 2005, Vol 51, Num 6, pp 339-346, issn 0009-3157, 8 p.Article
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococciLACY, M. K; TESSIER, P. R; NICOLAU, D. P et al.International journal of antimicrobial agents. 2000, Vol 15, Num 1, pp 25-30, issn 0924-8579Article
Influence of adjunctive interferon-γ on treatment of gentamicin-and vancomycin-resistant Enterococcus faecalis infection in miceONYEJI, C. O; BUI, K. Q; NICOLAU, D. P et al.International journal of antimicrobial agents. 1999, Vol 12, Num 4, pp 301-309, issn 0924-8579Article
Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection modelTESSIER, P. R; NICOLAU, D. P; ONYEJI, C. O et al.Chemotherapy (Basel). 1999, Vol 45, Num 4, pp 284-295, issn 0009-3157Article
Pharmacokinetics of ticlopidine in the rabbitONYEJI, C. O; TESSIER, P. R; NIGHTINGALE, C. H et al.Journal of pharmacy and pharmacology. 1999, Vol 51, Num 4, pp 393-396, issn 0022-3573Article
Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalisKLEPSER, M. E; PATEL, K. B; NICOLAU, D. P et al.Pharmacotherapy. 1998, Vol 18, Num 5, pp 1069-1074, issn 0277-0008Conference Paper
The pharmacodynamics of aminoglycosidesLACY, M. K; NICOLAU, D. P; NIGHTINGALE, C. H et al.Clinical infectious diseases. 1998, Vol 27, Num 1, pp 23-27, issn 1058-4838Conference Paper
Absorption of ciprofloxacin in febrile and afebrile patientsPATEL, K. B; BELLIVEAU, P. P; NIGHTINGALE, C. H et al.International journal of antimicrobial agents. 1995, Vol 6, Num 2, pp 119-122, issn 0924-8579Article
Cephalosporin-metronidazole combinations in the management of intra-abdominal infectionsNICOLAU, D. P; PATEL, K. B; QUINTILIANI, R et al.Diagnostic microbiology and infectious disease. 1995, Vol 22, Num 1-2, pp 189-194, issn 0732-8893Conference Paper
Comparative Efficacies of Human Simulated Exposures of Tedizolid and Linezolid against Staphylococcus aureus in the Murine Thigh Infection ModelKEEL, R. A; TESSIER, P. R; CRANDON, J. L et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 8, pp 4403-4407, issn 0066-4804, 5 p.Article
Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae : Implications for breakpoint determinationsNICOLAU, D. P; ONYEJI, C. O; MINGKANG ZHONG et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 5, pp 1291-1295, issn 0066-4804Article
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosaBUI, K. Q; BANEVICIUS, M. A; NIGHTINGALE, C. H et al.Journal of antimicrobial chemotherapy (Print). 2000, Vol 45, Num 1, pp 57-62, issn 0305-7453Article
Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis modelLACY, M. K; NICOLAU, D. P; BANEVICIUS, M. A et al.Journal of antimicrobial chemotherapy (Print). 1999, Vol 44, Num 4, pp 477-481, issn 0305-7453Article
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infectionLACY, M. K; WEN LU; XIAOWEI XU et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 3, pp 672-677, issn 0066-4804Article